Category: Product Safety & Regulation
Inactive Ingredient Differences: Can Excipients Affect Safety or Efficacy?
Excipients, or inactive ingredients, make up most of a pill's mass. New research shows some interact with biological targets, raising questions about safety and efficacy. Learn how regulations manage these risks.
May 9 2026
Dissolution Testing: How the FDA Ensures Generic Drug Quality
Discover how the FDA uses dissolution testing and bioequivalence standards to ensure generic drugs work exactly like brand-name versions, preventing risks like dose-dumping.
Apr 30 2026
How to Create a Personal Pharmacy Safety Checklist to Prevent Dispensing Errors
Learn how to prevent dispensing errors by implementing a personal pharmacy safety checklist. Discover tips for medication verification and reconciliation.
Apr 23 2026
How the FDA Monitors Generic Drug Safety After Approval
Learn how the FDA monitors generic drugs after approval using FAERS, the Sentinel Initiative, and cGMP inspections to ensure public safety.
Apr 16 2026
Understanding Manufacturer Reporting: Generic Company Safety Obligations Explained
Manufacturers must navigate complex safety reporting laws to avoid heavy fines. Learn the deadlines, agency requirements, and best practices for FDA, CPSC, and NHTSA compliance.
Mar 29 2026
